Mifepristone Ruling Risks 'Profound Disruption,' Justices Told
By Theresa Schliep · November 22, 2023, 4:06 PM EST
The U.S. Food and Drug Administration told the U.S. Supreme Court that a Fifth Circuit decision limiting access to the abortion medication mifepristone could create "profound disruption" for patients and medical professionals,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login